NCT00619710View on ClinicalTrials.gov

Complicated Skin and Skin Structure Infections

PHASE3CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

December 31, 2003

Study Completion Date

April 30, 2004

Conditions
Skin InfectionAbscessCellulitis
Interventions
DRUG

Meropenem

Intravenous

DRUG

Imipenem-cilastatin

Intravenous

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00619710 - Complicated Skin and Skin Structure Infections | Biotech Hunter | Biotech Hunter